Dr. Parham Ayazi, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4960 S Gilbert Rd Ste 1-203, Chandler, AZ 85249 Phone: 480-478-9029 Fax: 480-899-9328 |
Dr. Glenn Adrian Schnepf, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3284 E Birchwood Pl, Chandler, AZ 85249 Phone: 480-668-3904 Fax: 480-668-3904 |
Yumi Oh, MD Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 1955 W Frye Rd, Chandler, AZ 85224 Phone: 480-728-3000 Fax: 480-899-9328 |
Ramvinay S Seddabattula, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 W Chandler Blvd, Suite 160, Chandler, AZ 85224 Phone: 480-907-6337 Fax: 480-621-8107 |
Maheswar M Rao, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1600 W Chandler Blvd Ste 110, Chandler, AZ 85224 Phone: 520-296-1206 Fax: 520-296-7410 |
News Archive
A new study on lazy eye found that programmable electronic glasses help improve vision in children just as well as the more traditional treatment using eye patches. This "digital patch" is the first new effective treatment for lazy eye in half a century. Results from the first U.S. trial of this device will be presented at AAO 2015, the 119th Annual Meeting of the American Academy of Ophthalmology.
Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab (Opdivo™) and ipilimumab (Yervoy™) or nivolumab alone significantly increases progression-free survival (PFS) over using ipilimumab alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) simultaneously presented today at the American Society of Clinical Oncology (ASCO) annual meeting and published online in the New England Journal of Medicine (NEJM). Examining specific characteristics of each patient's tumor has also given researchers clearer understanding of which patients should receive the combination.
A £1 million study, being led by a team of multidisciplinary researchers at The University of Nottingham, is to look at whether nicotine replacement skin patches could help pregnant mums to stop smoking.
XIFIN Inc., the leading provider of revenue cycle management for diagnostic service providers, today announced that the company has been named to the 2010 Inc. 5000 list of fastest-growing private companies for the fourth consecutive year, ranking 1,447th. The company ranked No. 96 in Top Software Companies, and No. 34 in Top Companies in the San Diego Metro Area. The list is widely regarded to include the most innovative and entrepreneurial companies in the nation.
The blueberry, already labeled a "super fruit" for its power to potentially lower the risk of heart disease and cancer, also could be another weapon in the war against Alzheimer's disease. New research being presented today further bolsters this idea, which is being tested by many teams.
› Verified 8 days ago